News & Updates

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

18 Dec 2024 by

Treatment with tirzepatide reduced the risk of cardiovascular (CV) death and worsening heart failure (HF) in patients with HF with preserved ejection fraction (HFpEF) and obesity, according to the SUMMIT trial presented at AHA 2024.

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

18 Dec 2024

Chlorthalidone no better than hydrochlorothiazide for kidney health

17 Dec 2024 by

In the treatment of patients with hypertension, the use of chlorthalidone does not appear to yield superior kidney outcomes when compared with hydrochlorothiazide but is associated with an increased risk of hypokalemia, as reported in a study.

Chlorthalidone no better than hydrochlorothiazide for kidney health

17 Dec 2024

CV impact of COVID persists even years after infection

17 Dec 2024 by

A recent study points to interesting clinical and genetic associations with COVID-19, demonstrating that the disease continues to pose a significant public health burden with lingering adverse cardiovascular (CV) risk and genetic interaction with ABO blood types.

CV impact of COVID persists even years after infection

17 Dec 2024

Patient delay as bad as system delay for survival of STEMI patients

16 Dec 2024

Patient delay appears to be as troublesome as system delay when it comes to the incidence of in-hospital deaths among patients with ST-segment elevation myocardial infarction (STEMI) who are undergoing primary percutaneous coronary intervention (PCI), reveals a study.

Patient delay as bad as system delay for survival of STEMI patients

16 Dec 2024

Acute COPD exacerbations carry increased risk of myocardial infarction, pulmonary embolism

15 Dec 2024

Patients with chronic obstructive pulmonary disease (COPD) are at heightened risk of myocardial infarction (MI) and pulmonary embolism (PE) in the presence of acute exacerbations, according to a study.

Acute COPD exacerbations carry increased risk of myocardial infarction, pulmonary embolism

15 Dec 2024

No increased risk of brain bleed with DOAC vs antiplatelet therapy in AF patients

15 Dec 2024

In the treatment of patients with atrial fibrillation (AF), direct oral anticoagulants (DOACs) do not contribute to an increased risk of intracranial haemorrhage compared with antiplatelet therapy, according to the results of a systematic review and meta-analysis.

No increased risk of brain bleed with DOAC vs antiplatelet therapy in AF patients

15 Dec 2024

Risk of myasthenia gravis onset highest in first month after statin initiation

14 Dec 2024 by

A study investigating the association between the risk of myasthenia gravis (MG) and statin therapy found the risk of onset in patients with no prior history of MG and the risk of exacerbation among patients with pre-existing MG were the highest in the first month after initiating statins.

Risk of myasthenia gravis onset highest in first month after statin initiation

14 Dec 2024

Physically active children have healthier retinal vasculature

14 Dec 2024 by

The Hong Kong Children Eye Study in nearly 12,000 local children aged 6–8 years shows that increased physical activity is associated with healthier retinal microvasculature.

Physically active children have healthier retinal vasculature

14 Dec 2024

Does MI type matter when it comes to transfusion strategy for patients with MI, anaemia?

13 Dec 2024

In patients with acute myocardial infarction (MI) and anaemia, a restrictive blood transfusion strategy may potentially result in poorer outcomes for those with type 1 but not those with type 2 MI, according to a study.

Does MI type matter when it comes to transfusion strategy for patients with MI, anaemia?

13 Dec 2024

Sacubitril/valsartan protects against chemo-induced heart damage

12 Dec 2024 by

Use of the common heart failure medication sacubitril/valsartan helps reduce cardiotoxicity in high-risk cancer patients undergoing anthracycline therapy, according to the results of the SARAH trial.

Sacubitril/valsartan protects against chemo-induced heart damage

12 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

Chlorthalidone no better than hydrochlorothiazide for kidney health

Chlorthalidone no better than hydrochlorothiazide for kidney health

CV impact of COVID persists even years after infection

CV impact of COVID persists even years after infection

Patient delay as bad as system delay for survival of STEMI patients

Patient delay as bad as system delay for survival of STEMI patients

Acute COPD exacerbations carry increased risk of myocardial infarction, pulmonary embolism

Acute COPD exacerbations carry increased risk of myocardial infarction, pulmonary embolism

No increased risk of brain bleed with DOAC vs antiplatelet therapy in AF patients

No increased risk of brain bleed with DOAC vs antiplatelet therapy in AF patients

Risk of myasthenia gravis onset highest in first month after statin initiation

Risk of myasthenia gravis onset highest in first month after statin initiation

Physically active children have healthier retinal vasculature

Physically active children have healthier retinal vasculature

Does MI type matter when it comes to transfusion strategy for patients with MI, anaemia?

Does MI type matter when it comes to transfusion strategy for patients with MI, anaemia?

Sacubitril/valsartan protects against chemo-induced heart damage

Sacubitril/valsartan protects against chemo-induced heart damage